This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis. Objectives: To estimate the ...

This systematic review found that studies of case management interventions have adequate quality and, in many cases, show cost-effective or even cost-saving results. Results: A total of 29 studies ...

As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

Assessing drug cost avoidance in clinical trials: An observational study in a Spanish tertiary hospital. Growth factor use in patients with breast cancer treated with docetaxel, carboplatin, ...

In the economic analysis of the REVISE trial (E-REVISE), the incremental cost of randomization to IV pantoprazole (Protonix ...

Background:Patients with venous thromboembolism (VTE) require access to comprehensive physician and pharmacy benefits to prevent recurrence and hemorrhage. Before 2006, Massachusetts provided these ...

A study led by McMaster University researchers shows that a widely available and inexpensive medication not only prevents ...

Compared with standard care, using icosapent ethyl (Vascepa; Amarin) in patients with high cardiovascular risk whose triglyceride levels remain high despite statin therapy is a cost-effective strategy ...

Vaccines may be scientific wonders, but their value ultimately rests on how well we can get shots into people’s arms. This is an obvious but still overlooked truth that the COVID-19 pandemic has ...

VEN+O is a cost-effective treatment for untreated, fit CLL patients, offering superior progression-free survival and cost savings compared to most alternatives. The study used a cost-utility analysis, ...